The Role of Organic Small Molecules in Pain Management

In this review, a timeline starting at the willow bark and ending in the latest discoveries of analgesic and anti-inflammatory drugs will be discussed. Furthermore, the chemical features of the different small organic molecules that have been used in pain management will be studied. Then, the mechan...

Full description

Bibliographic Details
Main Authors: Sebastián A. Cuesta, Lorena Meneses
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/13/4029
id doaj-760674cce4394eeaaf7198892cb5f0e6
record_format Article
spelling doaj-760674cce4394eeaaf7198892cb5f0e62021-07-15T15:42:50ZengMDPI AGMolecules1420-30492021-07-01264029402910.3390/molecules26134029The Role of Organic Small Molecules in Pain ManagementSebastián A. Cuesta0Lorena Meneses1Laboratorio de Química Computacional, Facultad de Ciencias Exactas y Naturales, Escuela de Ciencias Químicas, Pontificia Universidad Católica del Ecuador, Av. 12 de Octubre 1076 Apartado, Quito 17-01-2184, EcuadorLaboratorio de Química Computacional, Facultad de Ciencias Exactas y Naturales, Escuela de Ciencias Químicas, Pontificia Universidad Católica del Ecuador, Av. 12 de Octubre 1076 Apartado, Quito 17-01-2184, EcuadorIn this review, a timeline starting at the willow bark and ending in the latest discoveries of analgesic and anti-inflammatory drugs will be discussed. Furthermore, the chemical features of the different small organic molecules that have been used in pain management will be studied. Then, the mechanism of different types of pain will be assessed, including neuropathic pain, inflammatory pain, and the relationship found between oxidative stress and pain. This will include obtaining insights into the cyclooxygenase action mechanism of nonsteroidal anti-inflammatory drugs (NSAID) such as ibuprofen and etoricoxib and the structural difference between the two cyclooxygenase isoforms leading to a selective inhibition, the action mechanism of pregabalin and its use in chronic neuropathic pain, new theories and studies on the analgesic action mechanism of paracetamol and how changes in its structure can lead to better characteristics of this drug, and cannabinoid action mechanism in managing pain through a cannabinoid receptor mechanism. Finally, an overview of the different approaches science is taking to develop more efficient molecules for pain treatment will be presented.https://www.mdpi.com/1420-3049/26/13/4029anti-inflammatory drugsQSARpain managementcyclooxygenasemultitarget drugcannabinoid
collection DOAJ
language English
format Article
sources DOAJ
author Sebastián A. Cuesta
Lorena Meneses
spellingShingle Sebastián A. Cuesta
Lorena Meneses
The Role of Organic Small Molecules in Pain Management
Molecules
anti-inflammatory drugs
QSAR
pain management
cyclooxygenase
multitarget drug
cannabinoid
author_facet Sebastián A. Cuesta
Lorena Meneses
author_sort Sebastián A. Cuesta
title The Role of Organic Small Molecules in Pain Management
title_short The Role of Organic Small Molecules in Pain Management
title_full The Role of Organic Small Molecules in Pain Management
title_fullStr The Role of Organic Small Molecules in Pain Management
title_full_unstemmed The Role of Organic Small Molecules in Pain Management
title_sort role of organic small molecules in pain management
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2021-07-01
description In this review, a timeline starting at the willow bark and ending in the latest discoveries of analgesic and anti-inflammatory drugs will be discussed. Furthermore, the chemical features of the different small organic molecules that have been used in pain management will be studied. Then, the mechanism of different types of pain will be assessed, including neuropathic pain, inflammatory pain, and the relationship found between oxidative stress and pain. This will include obtaining insights into the cyclooxygenase action mechanism of nonsteroidal anti-inflammatory drugs (NSAID) such as ibuprofen and etoricoxib and the structural difference between the two cyclooxygenase isoforms leading to a selective inhibition, the action mechanism of pregabalin and its use in chronic neuropathic pain, new theories and studies on the analgesic action mechanism of paracetamol and how changes in its structure can lead to better characteristics of this drug, and cannabinoid action mechanism in managing pain through a cannabinoid receptor mechanism. Finally, an overview of the different approaches science is taking to develop more efficient molecules for pain treatment will be presented.
topic anti-inflammatory drugs
QSAR
pain management
cyclooxygenase
multitarget drug
cannabinoid
url https://www.mdpi.com/1420-3049/26/13/4029
work_keys_str_mv AT sebastianacuesta theroleoforganicsmallmoleculesinpainmanagement
AT lorenameneses theroleoforganicsmallmoleculesinpainmanagement
AT sebastianacuesta roleoforganicsmallmoleculesinpainmanagement
AT lorenameneses roleoforganicsmallmoleculesinpainmanagement
_version_ 1721298754060943360